- Home
- DNLI vs APAM Comparison
DNLI vs APAM Comparison
Compare DNLI & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- APAM
- Stock Information
- Founded
- DNLI 2013
- APAM 1994
- Country
- DNLI United States
- APAM United States
- Employees
- DNLI N/A
- APAM N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- APAM Investment Managers
- Sector
- DNLI Health Care
- APAM Finance
- Exchange
- DNLI Nasdaq
- APAM Nasdaq
- Market Cap
- DNLI 3.3B
- APAM 2.8B
- IPO Year
- DNLI 2017
- APAM 2013
- Fundamental
- Price
- DNLI $21.93
- APAM $42.88
- Analyst Decision
- DNLI Strong Buy
- APAM Hold
- Analyst Count
- DNLI 13
- APAM 4
- Target Price
- DNLI $38.91
- APAM $44.13
- AVG Volume (30 Days)
- DNLI 1.1M
- APAM 430.8K
- Earning Date
- DNLI 02-25-2025
- APAM 01-31-2025
- Dividend Yield
- DNLI N/A
- APAM 7.65%
- EPS Growth
- DNLI N/A
- APAM 18.41
- EPS
- DNLI N/A
- APAM 3.60
- Revenue
- DNLI N/A
- APAM $1,063,748,000.00
- Revenue This Year
- DNLI N/A
- APAM $15.88
- Revenue Next Year
- DNLI $651.24
- APAM $9.20
- P/E Ratio
- DNLI N/A
- APAM $11.91
- Revenue Growth
- DNLI 204.74
- APAM 11.72
- 52 Week Low
- DNLI $14.56
- APAM $37.89
- 52 Week High
- DNLI $33.33
- APAM $49.54
- Technical
- Relative Strength Index (RSI)
- DNLI 51.28
- APAM 45.72
- Support Level
- DNLI $18.52
- APAM $39.86
- Resistance Level
- DNLI $22.37
- APAM $42.70
- Average True Range (ATR)
- DNLI 1.31
- APAM 0.93
- MACD
- DNLI 0.31
- APAM 0.13
- Stochastic Oscillator
- DNLI 88.57
- APAM 62.42
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a global investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are primarily offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.